BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21674735)

  • 1. Adeno-associated virus-mediated expression of acid sphingomyelinase decreases atherosclerotic lesion formation in apolipoprotein E(-/-) mice.
    Leger AJ; Mosquea LM; Li L; Chuang W; Pacheco J; Taylor K; Luo Z; Piepenhagen P; Ziegler R; Moreland R; Urabe A; Jiang C; Cheng SH; Yew NS
    J Gene Med; 2011 Jun; 13(6):324-32. PubMed ID: 21674735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression.
    Devlin CM; Leventhal AR; Kuriakose G; Schuchman EH; Williams KJ; Tabas I
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1723-30. PubMed ID: 18669882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of atherosclerosis in apolipoprotein-E-deficient mice following muscle transduction with adeno-associated virus vectors encoding human apolipoprotein-E.
    Harris JD; Schepelmann S; Athanasopoulos T; Graham IR; Stannard AK; Mohri Z; Hill V; Hassall DG; Owen JS; Dickson G
    Gene Ther; 2002 Jan; 9(1):21-9. PubMed ID: 11850719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete prevention of atherosclerosis in apoE-deficient mice by hepatic human apoE gene transfer with adeno-associated virus serotypes 7 and 8.
    Kitajima K; Marchadier DH; Miller GC; Gao GP; Wilson JM; Rader DJ
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1852-7. PubMed ID: 16763161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.
    Park TS; Panek RL; Mueller SB; Hanselman JC; Rosebury WS; Robertson AW; Kindt EK; Homan R; Karathanasis SK; Rekhter MD
    Circulation; 2004 Nov; 110(22):3465-71. PubMed ID: 15545514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV8-mediated hepatic expression of acid sphingomyelinase corrects the metabolic defect in the visceral organs of a mouse model of Niemann-Pick disease.
    Barbon CM; Ziegler RJ; Li C; Armentano D; Cherry M; Desnick RJ; Schuchman EH; Cheng SH
    Mol Ther; 2005 Sep; 12(3):431-40. PubMed ID: 16099409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
    Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
    Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?
    Reifenberg K; Lehr HA; Baskal D; Wiese E; Schaefer SC; Black S; Samols D; Torzewski M; Lackner KJ; Husmann M; Blettner M; Bhakdi S
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1641-6. PubMed ID: 15920030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.
    Tsukamoto K; Tangirala RK; Chun S; Usher D; Puré E; Rader DJ
    Mol Ther; 2000 Feb; 1(2):189-94. PubMed ID: 10933930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation delays atherosclerotic lesion development in apoE-deficient mice.
    Carnicer R; Navarro MA; Arbonés-Mainar JM; Acín S; Guzmán MA; Surra JC; Arnal C; de Las Heras M; Blanco-Vaca F; Osada J
    Life Sci; 2007 Jan; 80(7):638-43. PubMed ID: 17118406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic human Netrin-1 gene delivery by adeno-associated virus type 8 alters leukocyte accumulation and atherogenesis in vivo.
    Khan JA; Cao M; Kang BY; Liu Y; Mehta JL; Hermonat PL
    Gene Ther; 2011 May; 18(5):437-44. PubMed ID: 21160531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis signal-regulating kinase 1 deficiency accelerates hyperlipidemia-induced atheromatous plaques via suppression of macrophage apoptosis.
    Yamada S; Ding Y; Tanimoto A; Wang KY; Guo X; Li Z; Tasaki T; Nabesima A; Murata Y; Shimajiri S; Kohno K; Ichijo H; Sasaguri Y
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1555-64. PubMed ID: 21527753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
    Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
    J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice.
    Koga M; Kai H; Yasukawa H; Kato S; Yamamoto T; Kawai Y; Kusaba K; Seki Y; Kai M; Egashira K; Kataoka Y; Imaizumi T
    Hypertens Res; 2007 Mar; 30(3):259-67. PubMed ID: 17510508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
    Harrington SC; Simari RD; Conover CA
    Circ Res; 2007 Jun; 100(12):1696-702. PubMed ID: 17510462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes.
    't Hoen PA; Van der Lans CA; Van Eck M; Bijsterbosch MK; Van Berkel TJ; Twisk J
    Circ Res; 2003 Aug; 93(3):262-9. PubMed ID: 12829615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
    O'Brien KD; McDonald TO; Kunjathoor V; Eng K; Knopp EA; Lewis K; Lopez R; Kirk EA; Chait A; Wight TN; deBeer FC; LeBoeuf RC
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):785-90. PubMed ID: 15692094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(-/-)/low-density lipoprotein(-/-) double knockout mice.
    Langheinrich AC; Michniewicz A; Sedding DG; Walker G; Beighley PE; Rau WS; Bohle RM; Ritman EL
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):347-52. PubMed ID: 16293797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.